SHANNON DIGNAN: Open Payments
NPI 1710540901 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 13 payments from 7 companies in 2025. Trend: 2023 $207 · 2024 $476 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $202 |
| ABBVIE INC. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
| PFIZER INC. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, UBRELVY, XIFAXAN, Rybelsus, Dexcom G6 Transmitter, REZDIFFRA, VRAYLAR, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
